Denda T, Takashima A, Gamoh M, Iwanaga I, et al. Combination therapy of bevacizumab with either S-1 and irinotecan or mFOLFOX6/CapeOX as first-line treatment of metastatic colorectal cancer (TRICOLORE): Exploratory analysis of RAS status and primary tumour location in a randomised, open-label, phase Eur J Cancer 2021;154:296-306.
PMID: 34304054